Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers have used unsupervised machine learning to predict disease-causing properties in more than 36 million genetic variants across more than 3,200 disease-related genes.
New research shows horizontal gene transfer is predictable in bacteria by machine learning, a development that could lead to better weapons in the war against E. coli and other bacterial assailants that collaborate to conquer pharmacologic first responders.
Could AI help produce a unifying concept of human disease—one that might help prevent, mitigate or cure everything from birth defects and rare cancers to immune disorders and neurological defects?
The AI development team was guided by a sports-medicine specialist dubbed “the go-to orthopedic surgeon for many of the greatest athletes on the planet.”
More than one-quarter of the U.S. adult population has Gastroesophageal Reflux Disease, or GERD, and the condition saddles as many as 20% of its sufferers with Barrett’s esophagus. The latter is a serious risk factor for esophageal cancer.
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.
